Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 210 results for "mirati"

Mirati reports 4Q loss

Unfortunately we are unable to process your request at this time. This error is usually temporary. Please try again later. If you continue to experience this error, it may be caused by one of the following: You may want to scan your system ... Yahoo! Finance, 1 month ago

12 images for mirati

American Banking News, 1 month ago
Mideast Time, 1 month ago
KXXV-TV, 1 month ago, 2 months ago
Nasdaq, 2 months ago
Pharmaceutical Business Review, 3 months ago
KXXV-TV, 3 months ago
Sys-Con Media, 4 months ago
Emirates247, 5 months ago
Securities Technology Monitor, 5 months ago

Mirati Therapeutics beats by $0.06

Are you Bullish or Bearish on ? Bullish Bearish Results for ( ) Bullish Bearish Thanks for sharing your thoughts. Submit & View Results Skip to
 Seeking Alpha1 month ago

Can The Uptrend Continue for Mirati (MRTX)?

These 7 were hand-picked from the list of 220 Zacks Rank #1 Strong Buys with earnings estimate revisions that are sweeping upward. Their stock prices are expected to rise sooner than the others. Today, this Special Report will be available ...
 Zacks.com3 weeks ago

Mirati Therapeutics : Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update

/PRNewswire/ -- Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX) today reported financial results for the fourth quarter and twelve months ended December 31, 2014 and provided an update on its drug development programs. "Mirati was built on ...
 4 Traders4 weeks ago MIRATI THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)  4 Traders1 month ago Mirati Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update  SearchBug1 month ago Mirati Therapeutics Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business Update  BioSpace1 month ago

Mirati Therapeutics (MRTX) Jumps: Stock Moves Up 6.8%

Today, you are invited to download a free Special Report from Zacks Investment Research. It reveals five moves that could gain +100% and more in the next 12 months: One white-hot electronics company is launching a wave of 9 new products.
 Zacks.com1 month ago
Mideast Time

Mirati Therapeutics Given Consensus Rating of Buy by Brokerages (NASDAQ:MRTX)

Mirati Therapeutics (NASDAQ:MRTX) has been given a consensus rating of Buy by the seven ratings firms that are presently covering the stock, ARN reports . Six research analysts have rated the stock with a buy rating and one has issued a strong ...
 SleekMoney2 weeks ago Zacks: Analysts Set $28.60 Price Target for Mirati Therapeutics (NASDAQ:MRTX)  Mideast Time1 month ago Mirati Therapeutics Receives Average Recommendation of Strong Buy from Analysts (NASDAQ:MRTX)  WKRB News1 month ago Analysts Give $28.60 Consensus Target Price to Mirati Therapeutics (NASDAQ:MRTX)  WKRB News1 month ago

Is Mirati Therapeutics (MRTX) Stock a Solid Choice Right Now…

One stock that might be an intriguing choice for investors right now is Mirati Therapeutics, Inc. ( MRTX - Snapshot Report ). This is because this security in the Medical-Biomedical/Generic space is seeing solid earnings estimate revision ...
 Zacks.com2 weeks ago

Mirati Therapeutics Inc (MRTX) Drops 9.11% on March 23

Mirati Therapeutics Inc ($MRTX) was one of the Russell 2000's biggest losers for Monday March 23 as the stock slid 9.11% to $27.13, a loss of $-2.72 per share. Starting at an opening price of $29.97 a share, the stock traded between $27.07 and ...
 Equities.com3 weeks ago Mirati Therapeutics Inc (MRTX) is Trading Lower on Unusual Volume for March 23  Equities.com3 weeks ago Mirati Therapeutics Inc (MRTX) Hits New 52-week High During March 19 Session  Equities.com4 weeks ago Mirati Therapeutics Inc (MRTX) Jumps 7.3% on March 18  Equities.com1 month ago
American Banking News

Mirati Therapeutics Price Target Raised to $27.00 at Leerink Swann (MRTX)

Research analysts at Leerink Swann upped their price target on shares of Mirati Therapeutics (NASDAQ:MRTX) from $25.00 to $27.00 in a report released on Thursday. The firm currently has an outperform rating on the stock. Leerink Swann's target price ...
 Mideast Time1 month ago Leerink Swann Boosts Mirati Therapeutics Price Target to $27.00 (MRTX)  WKRB News1 month ago Equities Research Analysts Price Target Changes for March, 12th (BMY, EXPR, EXXI, FENR, INTC, MRTX, SIEN, STO, SUPN, TCY)  American Banking News1 month ago
Mideast Time

Mirati Therapeutics (MRTX) Posts Earnings Results, Beats Estimates By $0.06 EPS

Mirati Therapeutics (NASDAQ:MRTX) issued its quarterly earnings data on Wednesday. The company reported ($0.77) earnings per share for the quarter, beating the analysts consensus estimate of ($0.83) by $0.06, Analyst RN reports. On a related ...
 SleekMoney1 month ago Mirati Therapeutics (MRTX) Releases Earnings Results, Beats Expectations By $0.06 EPS  Mideast Time1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less